Unknown

Dataset Information

0

YAP Regulates Hematopoietic Stem Cell Formation in Response to the Biomechanical Forces of Blood Flow.


ABSTRACT: Hematopoietic stem and progenitor cells (HSPCs), first specified from hemogenic endothelium (HE) in the ventral dorsal aorta (VDA), support lifelong hematopoiesis. Their de novo production promises significant therapeutic value; however, current in vitro approaches cannot efficiently generate multipotent long-lived HSPCs. Presuming this reflects a lack of extrinsic cues normally impacting the VDA, we devised a human dorsal aorta-on-a-chip platform that identified Yes-activated protein (YAP) as a cyclic stretch-induced regulator of HSPC formation. In the zebrafish VDA, inducible Yap overexpression significantly increased runx1 expression in vivo and the number of CD41+ HSPCs downstream of HE specification. Endogenous Yap activation by lats1/2 knockdown or Rho-GTPase stimulation mimicked Yap overexpression and induced HSPCs in embryos lacking blood flow. Notably, in static human induced pluripotent stem cell (iPSC)-derived HE culture, compound-mediated YAP activation enhanced RUNX1 levels and hematopoietic colony-forming potential. Together, our findings reveal a potent impact of hemodynamic Rho-YAP mechanotransduction on HE fate, relevant to de novo human HSPC production.

SUBMITTER: Lundin V 

PROVIDER: S-EPMC7398148 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

YAP Regulates Hematopoietic Stem Cell Formation in Response to the Biomechanical Forces of Blood Flow.

Lundin Vanessa V   Sugden Wade W WW   Theodore Lindsay N LN   Sousa Patricia M PM   Han Areum A   Chou Stephanie S   Wrighton Paul J PJ   Cox Andrew G AG   Ingber Donald E DE   Goessling Wolfram W   Daley George Q GQ   North Trista E TE  

Developmental cell 20200206 4


Hematopoietic stem and progenitor cells (HSPCs), first specified from hemogenic endothelium (HE) in the ventral dorsal aorta (VDA), support lifelong hematopoiesis. Their de novo production promises significant therapeutic value; however, current in vitro approaches cannot efficiently generate multipotent long-lived HSPCs. Presuming this reflects a lack of extrinsic cues normally impacting the VDA, we devised a human dorsal aorta-on-a-chip platform that identified Yes-activated protein (YAP) as a  ...[more]

Similar Datasets

| S-EPMC2722870 | biostudies-literature
| S-EPMC9136892 | biostudies-literature
| S-EPMC5115706 | biostudies-literature
| S-EPMC3139389 | biostudies-literature
| S-EPMC2782763 | biostudies-literature
| S-EPMC5260904 | biostudies-literature
| S-EPMC8191295 | biostudies-literature
| S-EPMC4419354 | biostudies-literature
| S-EPMC4967558 | biostudies-literature
| S-EPMC6939534 | biostudies-literature